| Health / Medical Topics |
Aleglitazar
A dual peroxisome proliferator-activated receptor (PPAR) agonist, with hypoglycemic activity. Aleglitazar binds to both PPARalpha and PPARgamma and decreases plasma levels of glucose, LDL-C, triglycerides (TG) and increases HDL levels. This agent may be used for the treatment of diabetes and cardiovascular disease. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug that is used to treat certain skin conditions and is being studied in the treatment of cutaneous (skin-related) T-cell cancer…
A drug used to treat non-small cell lung cancer that has spread to other parts of the body and has a mutated…
A drug used to treat non-small cell lung cancer that has spread to other parts of the body and has a mutated…
An inherited immune disorder that occurs in young boys. It causes eczema (a type of skin inflammation), a decrease in the number…
A 6-maleimidocaproyl hydrazone derivative prodrug of the anthracycline antibiotic doxorubicin (DOXO-EMCH) with antineoplastic activity. Following intravenous administration, aldoxorubicin binds selectively to the…
Sodium transport across the tight epithelia of Na+ reabsorbing tissues such as the distal part of the kidney nephron and colon is…
